The civic record
Read. Follow. Verify.Georgia House Bill 420 requires certain health benefit policies to cover genetic testing for inherited cancer mutations and cancer imaging
Last action · April 4, 2025: House Withdrawn, RecommittedSponsors: Darlene Taylor and 5 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Georgia health benefit policies issued or renewed on or after July 1, 2025, must cover genetic testing for inherited cancer mutations and for individuals meeting specific clinical criteria, subject to policy s.
Insured residents with a personal or family history of cancer or an increased risk of the disease gain guaranteed health plan coverage for specialized genetic testing and imaging when recommended by a healthcare provider.
- House Bill 420 is a state legislative measure introduced in Georgia during the 2025-2026 legislative session to regulate health insurance coverage mandates. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Covered persons under health benefit policies
Health benefit policies must include coverage for genetic testing for inherited mutations and cancer imaging when recommended by a healthcare provider and meeting clinical guidelines.
Health benefit policy issuers
Issuers must provide coverage for genetic testing and cancer imaging in policies issued or renewed on or after July 1, 2025.
Healthcare providers
Providers must recommend genetic testing and cancer imaging in accordance with nationally recognized clinical practice guidelines for coverage to apply.
Key Facts
- Health benefit policies issued, delivered, executed, or renewed in Georgia on or after July 1, 2025, must cover genetic testing for inherited mutations for covered persons with a personal or family history of cancer.
- Such policies must also cover cancer imaging for covered persons with an increased risk of cancer when recommended by a healthcare provider.
- Covered genetic testing and cancer imaging must be recommended by a healthcare provider and align with nationally recognized clinical practice guidelines.
- The required coverage is subject to the cost-sharing requirements of the covered person's health benefit policy.
Show all 6 facts
- Provisions are structured to protect health savings account eligibility under Section 223 of the Internal Revenue Code as it existed on January 1, 2025.
- The Insurance Commissioner is directed to promulgate rules and regulations to implement the section in accordance with guidelines from professional medical organizations like the National Comprehensive Cancer Network.
Frequently Asked Questions
Who is eligible for covered genetic testing under this measure?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
7 actions- Apr 4, 2025HouseHouse Withdrawn, Recommitted
- Feb 26, 2025HouseCommitteeHouse Committee Favorably Reported By Substitute
- Feb 24, 2025HouseHouse Withdrawn, Recommitted
- Feb 20, 2025HouseCommitteeHouse Committee Favorably Reported By Substitute
- Feb 18, 2025HouseHouse Second Readers
- Feb 13, 2025HouseIntroducedHouse First Readers
Show 1 earlier action
- Feb 12, 2025HouseIntroducedHouse Hopper
Version history & redline
3 versions on fileLobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 1 more sponsor
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Mandated Insurance Coverage for Genetic Cancer Screening
The bill shifts state insurance requirements by explicitly mandating coverage for germline multi-gene testing and cancer imaging based on clinical practice guidelines.
Connected Entities
Sources
www.legis.ga.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 65)
- Controversy30Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools
